Get started
Gossamer Bio, Inc.Gossamer Bio, Inc.Gossamer Bio, Inc.

Gossamer Bio, Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Technicals Forecast

GOSS chart

Key stats

Market capitalization
‪193.57 M‬USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−1.3845USD
Net income
‪−179.82 M‬USD
Revenue
—
Shares float
‪188.87 M‬
Beta (1Y)
3.35

About Gossamer Bio, Inc.

Sector
Health Technology
CEO
Faheem Hasnain
Headquarters
San Diego
Website
gossamerbio.com
Employees (FY)
135
Founded
2015
ISIN
US38341P1021
FIGI
BBG00MVWLLM2
Gossamer Bio, Inc. engages in discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. Its primary product candidate, GB001, is intended for the treatment of moderate-to-severe eosinophilic asthma and other allergic conditions. The company was founded by Faheem Hasnain and Sheila Gujrathi in 2015 and is headquartered in San Diego, CA.

Financials

Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

Ideas

See all ideas 

News

Keep reading

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating

An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of GOSS is 0.82 USD — it has decreased by 4.35% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Gossamer Bio, Inc. stocks are traded under the ticker GOSS.
Gossamer Bio, Inc. is going to release the next earnings report on May 14, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for Gossamer Bio, Inc. has a max estimate of 15.00 USD and a min estimate of 0.50 USD.
GOSS earnings for the last quarter are −0.21 USD whereas the estimation was −0.26 USD which accounts for 18.11% surprise. Estimated earnings for the next quarter are −0.21 USD. See more details about Gossamer Bio, Inc. earnings.
Yes, you can track Gossamer Bio, Inc. financials in yearly and quarterly reports right on TradingView.
Like other stocks, GOSS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Gossamer Bio, Inc. stock right from TradingView charts — choose your broker and connect to your account.
GOSS reached its all-time high on Dec 12, 2019 with the price of 27.15 USD, and its all-time low was 0.45 USD and was reached on Oct 24, 2023.
See other stocks reaching their highest and lowest prices.
As of Apr 16, 2024, the company has 135.00 employees. See our rating of the largest employees — is Gossamer Bio, Inc. on this list?